drugset
drugset / Trial / NCT03714880

Cervical Preparation With Mifepristone Prior to Osmotic Dilators

NCT03714880 ↗

Phase 2 Terminated 44 enrolled University of California, Davis Society of Family Planning · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators plan to study the role of mifepristone prior to the placement of cervical osmotic dilators to evaluate if the medication helps increase the number of dilators. This may help improve safety of dilation and evacuation (D\&E) procedures.

Timeline

Start
2019-04-26
Primary completion
2021-02-26
Completion
2021-02-26

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment compounded by COVID-19”

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 200 mg Oral

Indications

No indication recorded.